UID:
almafu_9961427227302883
Format:
1 videorecording (45 min., 29 sec.)
,
004529
Content:
Audio-visual presentation : Normal lipid and lipoprotein physiology ; Abnormalities of lipid and lipoprotein physiology in obesity and related mechanisms ; Inflammation and obesity ; The benefit of weight reduction to favorably modify plasma lipids, lipoproteins and the inflammatory burden in obese patients.
Note:
Retrieved April 11, 2024, from https://hstalks.com/bs/566/.
,
Introduction -- Lipid and lipoprotein metabolism -- HDL metabolism -- Obesity,dyslipidemia,inflammation and ASCVD -- Obesity lipid/lipoprotein abnormalities -- The consequence of increase in total cholesterol -- And It's just not fasting TG -- Mechanisms of hepatic fatty acid to triglyceride -- Fatty acid metabolism -- Regulation of lipolysis -- The antilipolytic effect of insulin -- Response of FFA to insulin/glucose -- Insulin inhibition of FFA turnover -- Insulin action in the liver -- Is there an effect of CHO independent of insulin? -- Effect of SRIF on FFA -- Effect of SRIF on plasma glucose and insulin -- Effect of SRIF on hypertriglyceridemia -- Carbohydrate responsive elements -- SREBP-1c dependent genes in the liver -- ChREBP and SREBP-1c and hepatic lipogenesis -- Plasma VLDL-TG in obese and lean men/women -- VLDL TG kinetics in lean and obese men/women -- Plasma VLDL-TG kinetics in men/women -- VLDL TG clearance in lean and obese men/women -- Adipose tissue LPL responsiveness to insulin -- Patterns of body fat distribution -- Visceral adiposity: the critical adipose depot -- Visceral vs subcutaneous adipose tissue -- Banting lecture 1998 -- The clustering of risk factors for ASCVD (2) -- The reduction of HDL cholesterol in obese patients -- Age-adjusted prevalence of HDL cholesterol -- Pathogenesis of decreased HDL cholesterol -- A reason for reductions in HDL cholesterol -- HDL cholesterol and plasma TG -- Plasma levels of HDL particles in the MetS -- Production of HDL particles in the MetS -- Clearance of HDL particles in the MetS -- Pathogenesis of increased atherosclerosis -- The impact of cytokines on obesity and ASCVD -- Inflammatory markers and insulin resistance -- Elevated CRP levels in obese adults -- CRP in overweight and obese men and women -- Inflammation and obesity -- Obesity is associated with cytokine burden -- CRP and body composition -- Visceral adipose tissue/plasma CRP/oxidized LDL -- Changes in metabolic syndrome components -- BMI and CRP in adolescents -- Weight reduction modifies dyslipidemia -- Timing of lipid assessment is important -- Impact of weight reduction on lipids/lipoproteins(1) -- Impact of weight reduction on lipids/lipoproteins(2) -- Impact of weight reduction on plasma triglycerides -- The mechanisms for the reduction in TG in obese -- Molar ratio of VLDL TG/Apo B-100 -- Relative change in VLDL Apo B-100 secretion -- VLDL TG secretion: effect of weight reduction -- Impact of weight reduction on HDL cholesterol -- HDL cholesterol,weight reduction and stabilization -- Impact of weight reduction on HDL2 /HDL3 -- A diet restricted in total fat lowers HDL and LDL -- Impact of weight reduction on LDL cholesterol -- Change in CRP after 15% weight loss -- Effect of weight reduction on insulin sensitivity -- Effect of weight reduction on plasma hs-CRP -- Effect of weight reduction on interleukin-18 levels -- Gastric bypass and cytokines at 14 Mo -- Summary.
Language:
English
Bookmarklink
